Advertisement
Canada markets close in 1 hour 56 minutes
  • S&P/TSX

    21,877.79
    -133.93 (-0.61%)
     
  • S&P 500

    5,076.26
    +5.71 (+0.11%)
     
  • DOW

    38,522.40
    +18.71 (+0.05%)
     
  • CAD/USD

    0.7298
    -0.0022 (-0.31%)
     
  • CRUDE OIL

    82.57
    -0.79 (-0.95%)
     
  • Bitcoin CAD

    88,704.70
    -2,800.70 (-3.06%)
     
  • CMC Crypto 200

    1,401.63
    -22.47 (-1.58%)
     
  • GOLD FUTURES

    2,336.70
    -5.40 (-0.23%)
     
  • RUSSELL 2000

    1,995.94
    -6.70 (-0.33%)
     
  • 10-Yr Bond

    4.6580
    +0.0600 (+1.30%)
     
  • NASDAQ

    15,736.36
    +39.72 (+0.25%)
     
  • VOLATILITY

    15.69
    0.00 (0.00%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6821
    -0.0015 (-0.22%)
     

INNV ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of December 13, 2021 in the Class Action Filed on Behalf of InnovAge Holding Inc. Limited Shareholders

New York, New York--(Newsfile Corp. - October 19, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of InnovAge Holding Inc. (NASDAQ: INNV) alleging that the Company violated federal securities laws.

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired InnovAge common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's March 2021 initial public offering.
Lead Plaintiff Deadline: December 13, 2021
No obligation or cost to you.

Learn more about your recoverable losses in INNV:
https://www.kleinstocklaw.com/pslra-1/innovage-holding-inc-loss-submission-form?id=20555&from=5

InnovAge Holding Inc. NEWS - INNV NEWS

CLASS ACTION CASE DETAILS: The filed complaint alleges that InnovAge Holding Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) certain of InnovAge's facilities failed to provide covered services, provide accessible and adequate services, manage participants' medical situations, and oversee use of specialists; (2) as a result, the Company was reasonably likely to be subject to regulatory scrutiny, including by the Centers for Medicare and Medicaid Services; (3) as a result, there as a significant risk that CMS would suspend new enrollments pending an audit of the Company's services; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

ADVERTISEMENT

WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in InnovAge you have until December 13, 2021 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you purchased InnovAge securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.

HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the INNV lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link.

ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/100268